132 related articles for article (PubMed ID: 9285384)
1. Ultrasound studies of the intestinal wall in patients with cystic fibrosis.
Pohl M; Krackhardt B; Posselt HG; Lembcke B
J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):317-20. PubMed ID: 9285384
[TBL] [Abstract][Full Text] [Related]
2. Sonographic evaluation of bowel wall thickness in patients with cystic fibrosis.
Dialer I; Hundt C; Bertele-Harms RM; Harms HK
J Clin Gastroenterol; 2003 Jul; 37(1):55-60. PubMed ID: 12811210
[TBL] [Abstract][Full Text] [Related]
3. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis.
Mac Sweeney EJ; Oades PJ; Buchdahl R; Rosenthal M; Bush A
Lancet; 1995 Mar; 345(8952):752-6. PubMed ID: 7534369
[TBL] [Abstract][Full Text] [Related]
4. Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.
Haber HP; Benda N; Fitzke G; Lang A; Langenberg M; Riethmüller J; Stern M
Gut; 1997 Mar; 40(3):406-11. PubMed ID: 9135533
[TBL] [Abstract][Full Text] [Related]
5. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.
Connett GJ; Lucas JS; Atchley JT; Fairhurst JJ; Rolles CJ
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):181-3. PubMed ID: 10102230
[TBL] [Abstract][Full Text] [Related]
6. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
Ramsden WH; Moya EF; Littlewood JM
Arch Dis Child; 1998 Oct; 79(4):339-43. PubMed ID: 9875045
[TBL] [Abstract][Full Text] [Related]
7. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
[TBL] [Abstract][Full Text] [Related]
8. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States.
Freiman JP; FitzSimmons SC
J Pediatr Gastroenterol Nutr; 1996 Feb; 22(2):153-6. PubMed ID: 8642487
[TBL] [Abstract][Full Text] [Related]
9. Colonic wall thickening in cystic fibrosis identified by ultrasound.
Haber HP; Lang A; Drews K; Stern M
J Pediatr Gastroenterol Nutr; 1996 Nov; 23(4):487-91. PubMed ID: 8956194
[No Abstract] [Full Text] [Related]
10. Bowel ultrasound imaging in patients with cystic fibrosis: Relationship with clinical symptoms and CFTR genotype.
Fraquelli M; Baccarin A; Corti F; Conti CB; Russo MC; Della Valle S; Pozzi R; Cressoni M; Conte D; Colombo C
Dig Liver Dis; 2016 Mar; 48(3):271-6. PubMed ID: 26514737
[TBL] [Abstract][Full Text] [Related]
11. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.
Smyth RL; van Velzen D; Smyth AR; Lloyd DA; Heaf DP
Lancet; 1994 Jan; 343(8889):85-6. PubMed ID: 7903780
[TBL] [Abstract][Full Text] [Related]
12. The intestinal radiological changes in older people with pancreatic cystic fibrosis.
Bartram CI; Small E
Br J Radiol; 1971 Mar; 44(519):196-7. PubMed ID: 5548798
[No Abstract] [Full Text] [Related]
13. Incidence of distal intestinal obstruction syndrome in cystic fibrosis.
Rosenstein BJ; Langbaum TS
J Pediatr Gastroenterol Nutr; 1983 May; 2(2):299-301. PubMed ID: 6553601
[TBL] [Abstract][Full Text] [Related]
14. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
[TBL] [Abstract][Full Text] [Related]
16. Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome.
Declercq D; Van Biervliet S; Robberecht E
Nutr Clin Pract; 2015 Feb; 30(1):134-7. PubMed ID: 25288253
[TBL] [Abstract][Full Text] [Related]
17. Progressive pan-colonic fibrosis secondary to oral administration of pancreatic enzymes.
Moss RL; Musemeche CA; Feddersen RM
Pediatr Surg Int; 1998 Mar; 13(2-3):168-70. PubMed ID: 9563037
[TBL] [Abstract][Full Text] [Related]
18. Case report: colonic stricture and fibrosis associated with high-strength pancreatic enzymes in a child with cystic fibrosis.
McHugh K; Thomson A; Tam P
Br J Radiol; 1994 Sep; 67(801):900-1. PubMed ID: 7953234
[TBL] [Abstract][Full Text] [Related]
19. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
Pettei MJ; Leonidas JC; Levine JJ; Gorvoy JD
J Pediatr; 1994 Oct; 125(4):587-9. PubMed ID: 7931879
[TBL] [Abstract][Full Text] [Related]
20. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
Konstan MW; Stern RC; Trout JR; Sherman JM; Eigen H; Wagener JS; Duggan C; Wohl ME; Colin P
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
